1-20 of 24
Sort by
News

September 2022 Data Stream

Published: 2022
Abstract
September 2022
View News titled, September 2022 Data Stream
News

National Sickle Cell Awareness Month: Highlights of Sickle Cell Disease at ASH

Published: 2022
Abstract
September 2022
View News titled, National Sickle Cell Awareness Month: Highlights of Sickle Cell Disease at ASH
News

Five-Year Follow-Up of Ruxolitinib Trial Shows Durable Clinical Results in PV Without Splenomegaly

Lara C. Pullen, PhD
Published: 2022
Abstract
September 2022
View News titled, Five-Year Follow-Up of Ruxolitinib Trial Shows Durable Clinical Results in PV Without Splenomegaly
News

Venetoclax Proves Active in Newly Diagnosed AML

Leah Lawrence
Published: 2022
Abstract
September 2022
View News titled, Venetoclax Proves Active in Newly Diagnosed AML
News

Insights Into the Burden of MM on Caregivers

Lara C. Pullen, PhD
Published: 2022
Abstract
September 2022
View News titled, Insights Into the Burden of MM on Caregivers
News

AlloHCT Outcomes Improved in Adults With ALL

Lara C. Pullen, PhD
Published: 2022
Abstract
September 2022
View News titled, AlloHCT Outcomes Improved in Adults With ALL
News

Coagulation Effects Differ in Knee Arthroscopy and Casting After Leg Injury

Thomas R. Collins
Published: 2022
Abstract
September 2022
View News titled, Coagulation Effects Differ in Knee Arthroscopy and Casting After Leg Injury
News

Tool Assesses Quality of Life for Patients With HHT

Thomas R. Collins
Published: 2022
Abstract
September 2022
View News titled, Tool Assesses Quality of Life for Patients With HHT
News

Pooled Analysis Shows Good Results With Avapritinib in Previously Treated Advanced SM

Thomas R. Collins
Published: 2022
Abstract
September 2022
View News titled, Pooled Analysis Shows Good Results With Avapritinib in Previously Treated Advanced SM
News

Comparative Analysis Shows Axi-Cel Durable Treatment Benefit in R/R FL

Leah Lawrence
Published: 2022
Abstract
September 2022
View News titled, Comparative Analysis Shows Axi-Cel Durable Treatment Benefit in R/R FL
News

Azacitidine Approved for Juvenile Myelomonocytic Leukemia

Published: 2022
Abstract
September 2022
View News titled, Azacitidine Approved for Juvenile Myelomonocytic Leukemia
News

HHS Extends American Rescue Plan Spending Deadline by a Year

Published: 2022
Abstract
September 2022
View News titled, HHS Extends American Rescue Plan Spending Deadline by a Year
News

Breakthrough Therapy Designation Granted to Efanesoctocog Alfa for Hemophilia A

Published: 2022
Abstract
September 2022
View News titled, Breakthrough Therapy Designation Granted to Efanesoctocog Alfa for Hemophilia A
News

HCT and GT Show Similar Outcomes for ADA-SCID in the Contemporary Era

Tess Stafford
Published: 2022
Abstract
September 2022
View News titled, HCT and GT Show Similar Outcomes for ADA-SCID in the Contemporary Era
News

Umbralisib Approval for Lymphoma Indications Withdrawn

Published: 2022
Abstract
September 2022
View News titled, Umbralisib Approval for Lymphoma Indications Withdrawn
News

Tisagenlecleucel Approved for R/R FL

Published: 2022
Abstract
September 2022
View News titled, Tisagenlecleucel Approved for R/R FL
News

Pulling Back the Curtain: Thomas R. Chauncey, MD, PhD

Mary Ellen Schneider
Published: 2022
Abstract
September 2022 In this edition, Thomas R. Chauncey, MD, PhD, discusses his winding road to medicine and the joys and challenges of clinical care and trial work.
View News titled, Pulling Back the Curtain: Thomas R. Chauncey, MD, PhD
News

Thromboelastography: Measuring Blood Coagulation in Real Time

Anna Azvolinsky, PhD
Published: 2022
Abstract
September 2022
View News titled, Thromboelastography: Measuring Blood Coagulation in Real Time
News

Cardiovascular Disease and Myeloproliferative Neoplasms

Kimberly Retzlaff
Published: 2022
Abstract
September 2022
View News titled, Cardiovascular Disease and Myeloproliferative Neoplasms
News

You Make the Call: What would you advise when biopsy results show nodular lymphocyte-predominant Hodgkin lymphoma but lab and bone marrow tests are negative?

Published: 2022
Abstract
September 2022
View News titled, You Make the Call: What would you advise when biopsy results show nodular lymphocyte-predominant Hodgkin lymphoma but lab and bone marrow tests are negative?